:

Marya Getchell1, John Pastor Ansah2, Dodge Lim3

  • 1Duke-NUS Medical School, Program in Health Services and Systems Research, Singapore, Singapore. maya.getchell@gmail.com.

BMC public health
|November 5, 2025
PubMed
概括

基因Xpert XDR是一种具有成本效益的工具,用于在高负担国家检测耐药结核病 (DR-TB). 目标下一代测序 (tNGS) 在常规使用中成本效益较低,但可能有利于高风险群体.